Get the T1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR Qualitative Test for only $126 USD (regular $162). Detect leukemia-specific genetic abnormalities with advanced PCR technology. Available in New York
Get the TCF3-PBX1 PCR Qualitative Test for leukemia detection at $126 USD. Available across USA including New York T(1;19) q23;p13.3 TCF3-PBX1 PCR Qualitative Test Original price was: $162.Current price is: $126.
Get comprehensive Thalassemia Beta Trio Prenatal Mutation Detection testing for $526 USD across USA. Early detection of beta-thalassemia mutations in parents and fetus. Available in New York Thalassemia Beta Trio Prenatal Mutation Detection Test Original price was: $586.Current price is: $526.
Sale!

T1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR Qualitative Test

Original price was: $162.Current price is: $126.

-22%

The T1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR Qualitative Test is a sophisticated molecular diagnostic tool designed to detect the specific genetic translocation associated with acute lymphoblastic leukemia (ALL). This test identifies the fusion of ETV6 and RUNX1 genes, also known as TEL-AML1, which represents the most common genetic abnormality in childhood ALL. Using advanced Real-Time PCR technology, the test provides highly sensitive detection of minimal residual disease and helps guide treatment decisions. Patients with suspected or diagnosed leukemia benefit from this precise genetic analysis for accurate diagnosis, prognosis assessment, and treatment monitoring. The test requires a 3 mL whole blood or bone marrow sample collected in EDTA tubes and processed with clinical history. Available for $126 USD (discounted from $162), this test offers crucial insights for leukemia management across our nationwide network of diagnostic centers.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

T1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR Qualitative Test

Understanding the ETV6-RUNX1 Genetic Translocation Test

The T1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR Qualitative Test represents a cutting-edge molecular diagnostic approach for detecting one of the most significant genetic abnormalities in leukemia. This sophisticated test specifically identifies the chromosomal translocation between chromosomes 12 and 21, resulting in the fusion of ETV6 (TEL) and RUNX1 (AML1) genes. This genetic rearrangement creates a powerful oncogene that drives the development of acute lymphoblastic leukemia, particularly in pediatric patients.

What This Advanced Test Detects

This specialized PCR-based test precisely measures the presence of the ETV6-RUNX1 fusion gene, which occurs when genetic material from chromosome 12’s ETV6 gene combines with chromosome 21’s RUNX1 gene. The detection capabilities include:

  • Presence or absence of the ETV6-RUNX1 fusion transcript
  • Qualitative assessment of the genetic translocation
  • Identification of this specific leukemia-associated genetic marker
  • Detection of minimal residual disease during treatment monitoring

Who Should Consider This Genetic Test

This test is particularly valuable for individuals presenting with:

  • Suspected or newly diagnosed acute lymphoblastic leukemia (ALL)
  • Unexplained fatigue, bruising, or recurrent infections
  • Abnormal blood cell counts requiring further investigation
  • Children with leukemia symptoms requiring precise genetic characterization
  • Patients undergoing leukemia treatment needing minimal residual disease monitoring
  • Individuals with family history of hematological malignancies

Significant Benefits of Genetic Leukemia Testing

Choosing the ETV6-RUNX1 PCR test provides multiple clinical advantages:

  • Precise Diagnosis: Confirms specific genetic subtype of leukemia for targeted treatment
  • Prognostic Information: Helps predict disease course and treatment response
  • Treatment Guidance: Informs chemotherapy and targeted therapy decisions
  • Monitoring Capability: Tracks treatment effectiveness through minimal residual disease detection
  • Early Detection: Identifies genetic abnormalities before full disease manifestation
  • Family Risk Assessment: Provides insights for genetic counseling when appropriate

Understanding Your Test Results

Your ETV6-RUNX1 PCR test results will be interpreted by our expert molecular pathologists:

  • Positive Result: Indicates presence of ETV6-RUNX1 fusion gene, confirming this specific leukemia subtype
  • Negative Result: Suggests absence of this particular genetic abnormality
  • Clinical Correlation: Results are interpreted in context of complete clinical picture
  • Follow-up Recommendations: Specific guidance based on results and clinical scenario
  • Treatment Implications: Results may influence chemotherapy intensity and duration

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $126
Regular Price $162

Nationwide Access to Advanced Genetic Testing

We proudly serve patients across the United States with comprehensive diagnostic services. Our network includes specialized testing facilities in:

  • New York City and surrounding metropolitan areas
  • Los Angeles and Southern California regions
  • Chicago and Midwest locations
  • Houston, Dallas, and Texas centers
  • Major cities throughout all 50 states

Schedule Your Genetic Test Today

Take the first step toward precise leukemia diagnosis and management. Our experienced team is ready to assist you with:

  • Convenient appointment scheduling
  • Professional sample collection
  • Expert result interpretation
  • Comprehensive follow-up guidance

Call us now at +1(267) 388-9828 to book your T1221 p13q22 ETV6-RUNX1 TEL-AML1 PCR Qualitative Test or schedule online through our secure patient portal. Our genetic specialists are available to answer your questions and guide you through the testing process.

Test Specifications

  • Turnaround Time: Samples collected by Monday/Thursday by 11 AM; Reports available Wednesday/Saturday
  • Sample Type: 3 mL (2 mL minimum) whole blood or bone marrow in Lavender Top (EDTA) tube
  • Shipping Instructions: Ship refrigerated. DO NOT FREEZE
  • Required Information: Complete clinical history is mandatory for accurate interpretation
  • Testing Methodology: Real-Time PCR (Polymerase Chain Reaction)
  • Specialty: Oncologist-recommended molecular diagnostics
SKU: 2088 Category:

Related products